Yukio Fujiwara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yukio Fujiwara has a total of 346 co-authors. Here are the top co-authors by number of shared publications:
- Yoshihiro Komohara
Department of Cell Pathology Graduate School of Medical Sciences Kumamoto University Kumamoto Japan
23 shared publications Cheng Pan
Department of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan
11 shared publicationsYoshihiro Komohara
Department of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan
10 shared publicationsHiromu Yano
Department of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan
9 shared publications- Yoichi Saito
Laboratory of Bioengineering, Faculty of Advanced Science and Technology Kumamoto University Kumamoto Japan
8 shared publications - Hiromu Yano
Department of Tumor Pathology, Faculty of Life Sciences Kumamoto University Kumamoto Japan
5 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Elsevier in Results in Engineering
- Vol. 32
Development of macrophage transducer-based cancer diagnostics: A proof-of-concept microfluidic platform for profiling macrophage responses to cancer-cell-derived factors
- 12 October 2026
- Published by Elsevier in Results in Engineering
- Vol. 32
Open AccessDevelopment of macrophage transducer-based cancer diagnostics: A proof-of-concept microfluidic platform for profiling macrophage responses to cancer-cell-derived factors
- 27 August 2026
- Published by Wiley in The Journal of Pathology
- Vol. 270 (3) , 396-407
Aberrant SOX9 expression mediated by protumour macrophages predicts poorer clinical outcomes in hepatoblastoma
Tumour‐associated macrophages (TAMs) are known to promote tumour progression in many kinds of malignant tumour, including hepatoblastoma (HB). Based on previous studies, we suggested that TAM‐mediated sex‐determining region Y‐box 9 (SOX9) signal might enhance HB progression. The present study investigated the significance of the SOX9 signal in HB and examined the mechanisms underlying cell–cell interactions between tumour cells and TAMs. Co‐culture with human monocyte‐derived macrophages increased SOX9 expression in HB cell lines. Immunohistochemical analysis of HB samples revealed a positive correlation between SOX9 expression and TAM infiltration, and SOX9 expression was predominantly observed in the embryonal subtype. Increased SOX9 expression was associated with shorter 5‐year recurrence‐free and overall survival. Yes‐associated protein (YAP)/transcriptional co‐activator with PDZ‐binding motif (TAZ) signalling was found to be involved in macrophage‐induced SOX9 upregulation. The Wnt/β‐catenin pathway was also activated by co‐culture with macrophages and appeared to be upregulated by SOX9 expression. In summary, SOX9 was identified as a poor prognostic factor in HB, with expression enhanced by macrophage‐derived factors. The YAP/TAZ and Wnt/β‐catenin pathways are critical for cell–cell communication and are linked to SOX9 overexpression. © 2026 The Pathological Society of Great Britain and Ireland.
- 27 August 2026
- Published by Wiley in The Journal of Pathology
- Vol. 270 (3) , 396-407
Aberrant SOX9 expression mediated by protumour macrophages predicts poorer clinical outcomes in hepatoblastoma
Tumour‐associated macrophages (TAMs) are known to promote tumour progression in many kinds of malignant tumour, including hepatoblastoma (HB). Based on previous studies, we suggested that TAM‐mediated sex‐determining region Y‐box 9 (SOX9) signal might enhance HB progression. The present study investigated the significance of the SOX9 signal in HB and examined the mechanisms underlying cell–cell interactions between tumour cells and TAMs. Co‐culture with human monocyte‐derived macrophages increased SOX9 expression in HB cell lines. Immunohistochemical analysis of HB samples revealed a positive correlation between SOX9 expression and TAM infiltration, and SOX9 expression was predominantly observed in the embryonal subtype. Increased SOX9 expression was associated with shorter 5‐year recurrence‐free and overall survival. Yes‐associated protein (YAP)/transcriptional co‐activator with PDZ‐binding motif (TAZ) signalling was found to be involved in macrophage‐induced SOX9 upregulation. The Wnt/β‐catenin pathway was also activated by co‐culture with macrophages and appeared to be upregulated by SOX9 expression. In summary, SOX9 was identified as a poor prognostic factor in HB, with expression enhanced by macrophage‐derived factors. The YAP/TAZ and Wnt/β‐catenin pathways are critical for cell–cell communication and are linked to SOX9 overexpression. © 2026 The Pathological Society of Great Britain and Ireland.
- Open Access
- 24 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1852700
CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies
CD169 + macrophages are strategically positioned in secondary lymphoid organs and diverse peripheral tissues, where they orchestrate tissue-specific immune homeostasis by regulating local cellular and humoral responses. In the context of cancer, CD169 + macrophages within tumor-draining lymph nodes (tdLNs) and the tumor microenvironment (TME) have emerged as critical determinants of clinical outcome across multiple malignancies, acting as key modulators of both tumor progression and tumor control. In this review, we delineate the distinct yet complementary roles of CD169 + macrophages in tdLNs and the TME, with particular emphasis on their molecular and cellular interactions with cancer cells and immune effector populations, and on how these interactions shape systemic anticancer immunity. We further discuss the translational significance of CD169 + macrophages as prognostic and predictive biomarkers, and propose immunotherapeutic strategies that selectively target or exploit these cells to enhance antitumor responses. By integrating current experimental and clinical evidence, this review aims to refine our understanding of CD169 + macrophage biology and to highlight their potential as actionable targets in cancer diagnosis and treatment.
- 24 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1852700
Open AccessCD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies
CD169 + macrophages are strategically positioned in secondary lymphoid organs and diverse peripheral tissues, where they orchestrate tissue-specific immune homeostasis by regulating local cellular and humoral responses. In the context of cancer, CD169 + macrophages within tumor-draining lymph nodes (tdLNs) and the tumor microenvironment (TME) have emerged as critical determinants of clinical outcome across multiple malignancies, acting as key modulators of both tumor progression and tumor control. In this review, we delineate the distinct yet complementary roles of CD169 + macrophages in tdLNs and the TME, with particular emphasis on their molecular and cellular interactions with cancer cells and immune effector populations, and on how these interactions shape systemic anticancer immunity. We further discuss the translational significance of CD169 + macrophages as prognostic and predictive biomarkers, and propose immunotherapeutic strategies that selectively target or exploit these cells to enhance antitumor responses. By integrating current experimental and clinical evidence, this review aims to refine our understanding of CD169 + macrophage biology and to highlight their potential as actionable targets in cancer diagnosis and treatment.
- Open Access
- 8 May 2026
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (5) , 1507-1517
Clinical Significance of PD ‐ L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy
Despite recent advances in multimodal therapy, esophageal squamous cell carcinoma (ESCC) remains a highly lethal malignancy. Although immune checkpoint inhibitors (ICIs) have improved clinical outcomes, predictive biomarkers are urgently needed. This study aimed to investigate immune‐related features in tumor cells and the tumor microenvironment in pathological specimens from 45 patients with ESCC treated with ICIs for postoperative recurrence after curative resection. Immunohistochemistry and quantitative image analysis of CD3, CD8, FoxP3, CD163, PD‐L1, HLA‐A/B/C, and HLA‐DR were conducted. High programmed death‐ligand 1 (PD‐L1) expression in tumor‐associated macrophages (TAMs) and tumor cells was significantly associated with a favorable response. Infiltration of T cells, regulatory T cells, and TAMs was not associated with the clinical response, but increased T‐cell infiltration was closely associated with high PD‐L1 expression in TAMs. Downregulation of HLA‐A/B/C and ectopic HLA‐DR expression was seen in responders. High PD‐L1 expression in TAMs was closely related to increased T‐cell infiltration, and single‐cell RNA‐sequence analysis suggested a significant correlation with T‐cell proliferation. Collectively, these findings indicate that not only PD‐L1, but also HLA expression is useful for predicting the effectiveness of ICI therapy in patients with ESCC.
- 8 May 2026
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (5) , 1507-1517
Open AccessClinical Significance of PD ‐ L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy
Despite recent advances in multimodal therapy, esophageal squamous cell carcinoma (ESCC) remains a highly lethal malignancy. Although immune checkpoint inhibitors (ICIs) have improved clinical outcomes, predictive biomarkers are urgently needed. This study aimed to investigate immune‐related features in tumor cells and the tumor microenvironment in pathological specimens from 45 patients with ESCC treated with ICIs for postoperative recurrence after curative resection. Immunohistochemistry and quantitative image analysis of CD3, CD8, FoxP3, CD163, PD‐L1, HLA‐A/B/C, and HLA‐DR were conducted. High programmed death‐ligand 1 (PD‐L1) expression in tumor‐associated macrophages (TAMs) and tumor cells was significantly associated with a favorable response. Infiltration of T cells, regulatory T cells, and TAMs was not associated with the clinical response, but increased T‐cell infiltration was closely associated with high PD‐L1 expression in TAMs. Downregulation of HLA‐A/B/C and ectopic HLA‐DR expression was seen in responders. High PD‐L1 expression in TAMs was closely related to increased T‐cell infiltration, and single‐cell RNA‐sequence analysis suggested a significant correlation with T‐cell proliferation. Collectively, these findings indicate that not only PD‐L1, but also HLA expression is useful for predicting the effectiveness of ICI therapy in patients with ESCC.
- 25 February 2026
- Published by Wiley in Hepatology Research
- Vol. 56 (6) , 933-943
Regeneration of the Human Intrahepatic Nervous System in Living Donor Liver Transplantation Recipients
Aim: Nerve fibers in the liver help to regulate blood flow and metabolism. They spread from the porta hepatis along the Glissonean sheath (GS) to the hepatocytes and the surrounding areas. In liver transplants, these nerves are completely resected, but their regeneration is not well known. This study examined how and when these nerves regenerate following living donor liver transplantation (LDLT). Methods: The study included 7 patients who underwent LDLT, with follow‐up periods ranging from 5 to 27 years. Six patients underwent follow‐up biopsies, and 1 patient underwent whole‐liver re‐transplantation. A biopsy specimen obtained during transplantation was used as the control. Nerve regeneration was assessed using synaptophysin immunohistological staining to detect nerve fibers. Results: In 6 cases, nerve fibers disappeared soon after the transplant and were not observed for months or years. In three cases with follow‐up periods exceeding 15 years, nerve fibers were observed around the GS only after more than 15 years had elapsed. In the re‐transplanted liver, thick nerve fibers grew around the large GS, but thin fibers did not appear around the smaller GS or within liver lobules. Conclusions: Nerve fibers from donor liver diminished immediately after LDLT. They grew mainly around the medium to large GS, with little or no growth within the lobules.
- 25 February 2026
- Published by Wiley in Hepatology Research
- Vol. 56 (6) , 933-943
Regeneration of the Human Intrahepatic Nervous System in Living Donor Liver Transplantation Recipients
Aim: Nerve fibers in the liver help to regulate blood flow and metabolism. They spread from the porta hepatis along the Glissonean sheath (GS) to the hepatocytes and the surrounding areas. In liver transplants, these nerves are completely resected, but their regeneration is not well known. This study examined how and when these nerves regenerate following living donor liver transplantation (LDLT). Methods: The study included 7 patients who underwent LDLT, with follow‐up periods ranging from 5 to 27 years. Six patients underwent follow‐up biopsies, and 1 patient underwent whole‐liver re‐transplantation. A biopsy specimen obtained during transplantation was used as the control. Nerve regeneration was assessed using synaptophysin immunohistological staining to detect nerve fibers. Results: In 6 cases, nerve fibers disappeared soon after the transplant and were not observed for months or years. In three cases with follow‐up periods exceeding 15 years, nerve fibers were observed around the GS only after more than 15 years had elapsed. In the re‐transplanted liver, thick nerve fibers grew around the large GS, but thin fibers did not appear around the smaller GS or within liver lobules. Conclusions: Nerve fibers from donor liver diminished immediately after LDLT. They grew mainly around the medium to large GS, with little or no growth within the lobules.
- Open Access
- 23 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Histone demethylase KDM7A negatively regulates fibrotic macrophage polarization and lung fibrosis progression
Macrophage polarization shapes immune responses in inflammation and fibrosis, yet the epigenetic mechanisms restraining pathogenic states remain unclear. Here, we identify lysine-specific demethylase 7 A (KDM7A) as an epigenetic suppressor of a profibrotic macrophage (Fib-Mac). Using macrophage assays, single-cell RNA sequencing of Kdm7a-knockout mice, and lung tissue from fibrosis patients, we show that Kdm7a loss drives transcriptional and metabolic reprogramming toward Fib-Mac states. Kdm7a-knockout mice exhibit exacerbated bleomycin-induced lung fibrosis with the expansion of Fib-Mac populations. Mechanistically, we identify toll-like receptor 8 (TLR8) as a suppressor of Fib-Mac polarization whose expression is regulated by KDM7A via the repressive mark H3K27me2 at its enhancer. Notably, macrophage Kdm7a and Tlr8 expression declines with age in male mice, consistent with clinical risk patterns. These findings uncover an epigenetic mechanism restraining disease-driving macrophage states and suggest the KDM7A-TLR8 axis as a potential therapeutic target in fibrotic disorders.
- 23 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessHistone demethylase KDM7A negatively regulates fibrotic macrophage polarization and lung fibrosis progression
Macrophage polarization shapes immune responses in inflammation and fibrosis, yet the epigenetic mechanisms restraining pathogenic states remain unclear. Here, we identify lysine-specific demethylase 7 A (KDM7A) as an epigenetic suppressor of a profibrotic macrophage (Fib-Mac). Using macrophage assays, single-cell RNA sequencing of Kdm7a-knockout mice, and lung tissue from fibrosis patients, we show that Kdm7a loss drives transcriptional and metabolic reprogramming toward Fib-Mac states. Kdm7a-knockout mice exhibit exacerbated bleomycin-induced lung fibrosis with the expansion of Fib-Mac populations. Mechanistically, we identify toll-like receptor 8 (TLR8) as a suppressor of Fib-Mac polarization whose expression is regulated by KDM7A via the repressive mark H3K27me2 at its enhancer. Notably, macrophage Kdm7a and Tlr8 expression declines with age in male mice, consistent with clinical risk patterns. These findings uncover an epigenetic mechanism restraining disease-driving macrophage states and suggest the KDM7A-TLR8 axis as a potential therapeutic target in fibrotic disorders.
- Open Access
- 21 January 2026
- Published by Wiley in Microbiology and Immunology
- Vol. 70 (3) , 148-159
Therapeutic Efficacy of the Supersulfide Donor NAC‐S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses
Influenza pneumonia is characterized by excessive inflammatory responses that contribute to severe lung injury and mortality. Supersulfides, endogenously produced cysteine‐derived persulfides and polysulfides, exert potent antioxidant, anti‐ferroptotic, and anti‐inflammatory activities; however, their therapeutic potential after disease onset remains unclear. Here, we investigated the efficacy of N ‐acetylcysteine tetrasulfide (NAC‐S2), a highly water‐soluble and cell‐permeable supersulfide donor, in a mouse model of influenza A virus (IAV)‐induced pneumonia. Subcutaneous administration of NAC‐S2 rapidly elevated systemic levels of cysteine‐ and glutathione‐derived supersulfides. In therapeutic treatment starting 2 days post‐infection, when body weight loss and clinical signs had already developed, NAC‐S2 significantly improved survival and mitigated body weight loss compared with vehicle and oxidized NAC controls. Metabolomic analysis revealed that influenza virus infection depleted lung glutathione persulfide (GSSH), while NAC‐S2 effectively restored tissue GSSH levels. NAC‐S2 treatment markedly reduced pulmonary interleukin (IL)−1β and IL‐6 production without affecting viral load or Type‐I interferon responses. Furthermore, NAC‐S2 suppressed NLRP3 inflammasome activation and gasdermin D expression, leading to decreased infiltration of CD3 + T cells and myeloperoxidase‐positive neutrophils. Histopathological analyses confirmed that NAC‐S2 ameliorated epithelial injury, interstitial edema, and hemorrhage in infected lungs. Collectively, our findings demonstrate that NAC‐S2 exerts therapeutic benefit even after the onset of severe influenza pneumonia, primarily by replenishing supersulfides and alleviating excessive inflammatory responses. Supersulfide donors represent a promising class of adjunctive therapeutics for severe viral pneumonia.
- 21 January 2026
- Published by Wiley in Microbiology and Immunology
- Vol. 70 (3) , 148-159
Open AccessTherapeutic Efficacy of the Supersulfide Donor NAC‐S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses
Influenza pneumonia is characterized by excessive inflammatory responses that contribute to severe lung injury and mortality. Supersulfides, endogenously produced cysteine‐derived persulfides and polysulfides, exert potent antioxidant, anti‐ferroptotic, and anti‐inflammatory activities; however, their therapeutic potential after disease onset remains unclear. Here, we investigated the efficacy of N ‐acetylcysteine tetrasulfide (NAC‐S2), a highly water‐soluble and cell‐permeable supersulfide donor, in a mouse model of influenza A virus (IAV)‐induced pneumonia. Subcutaneous administration of NAC‐S2 rapidly elevated systemic levels of cysteine‐ and glutathione‐derived supersulfides. In therapeutic treatment starting 2 days post‐infection, when body weight loss and clinical signs had already developed, NAC‐S2 significantly improved survival and mitigated body weight loss compared with vehicle and oxidized NAC controls. Metabolomic analysis revealed that influenza virus infection depleted lung glutathione persulfide (GSSH), while NAC‐S2 effectively restored tissue GSSH levels. NAC‐S2 treatment markedly reduced pulmonary interleukin (IL)−1β and IL‐6 production without affecting viral load or Type‐I interferon responses. Furthermore, NAC‐S2 suppressed NLRP3 inflammasome activation and gasdermin D expression, leading to decreased infiltration of CD3 + T cells and myeloperoxidase‐positive neutrophils. Histopathological analyses confirmed that NAC‐S2 ameliorated epithelial injury, interstitial edema, and hemorrhage in infected lungs. Collectively, our findings demonstrate that NAC‐S2 exerts therapeutic benefit even after the onset of severe influenza pneumonia, primarily by replenishing supersulfides and alleviating excessive inflammatory responses. Supersulfide donors represent a promising class of adjunctive therapeutics for severe viral pneumonia.
- Open Access
- 9 January 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 15
Mycobacterium avium infection induced PD-L1 overexpression in macrophages: a potential involvement with immune escape
Non-tuberculous mycobacteria (NTM) infections are difficult to cure completely with current treatments, and no specific drugs are available. However, recent reports have indicated that immune checkpoint inhibitors may effectively treat pulmonary NTM infections. In this study, we investigated the expression of immune checkpoint molecules in macrophages, the host cells of NTM, and assessed their impact on the microenvironment of infected lesions. Bulk-RNA sequencing and western blot analyses revealed that macrophages infected with Mycobacterium avium , an NTM species, exhibited a pro-inflammatory phenotype and increased PD-L1 expression. Additionally, immunostaining of an NTM-infected mouse model and human tissues showed that increased PD-L1 expression in macrophages was associated with decreased T cell infiltration and increased T cell exhaustion (upregulated PD-1 expression) within infected lesions. These findings suggest that NTM infections evade cellular immunity by enhancing PD-L1 expression in macrophages. Therefore, PD-L1 inhibition may be a promising therapeutic strategy against NTM infections.
- 9 January 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 15
Open AccessMycobacterium avium infection induced PD-L1 overexpression in macrophages: a potential involvement with immune escape
Non-tuberculous mycobacteria (NTM) infections are difficult to cure completely with current treatments, and no specific drugs are available. However, recent reports have indicated that immune checkpoint inhibitors may effectively treat pulmonary NTM infections. In this study, we investigated the expression of immune checkpoint molecules in macrophages, the host cells of NTM, and assessed their impact on the microenvironment of infected lesions. Bulk-RNA sequencing and western blot analyses revealed that macrophages infected with Mycobacterium avium , an NTM species, exhibited a pro-inflammatory phenotype and increased PD-L1 expression. Additionally, immunostaining of an NTM-infected mouse model and human tissues showed that increased PD-L1 expression in macrophages was associated with decreased T cell infiltration and increased T cell exhaustion (upregulated PD-1 expression) within infected lesions. These findings suggest that NTM infections evade cellular immunity by enhancing PD-L1 expression in macrophages. Therefore, PD-L1 inhibition may be a promising therapeutic strategy against NTM infections.
- 12 November 2025
- Published by Wiley in Pathology International
- Vol. 75 (11) , 551-561
Therapeutic Strategies Targeting CD163 and CD169 in Macrophages for Cancer
Macrophage activation markers, specifically CD163 and CD169, play pivotal roles in the modulation of immune responses within the tumor microenvironment (TME), influencing the outcome of various cancers. These markers delineate the activation states of macrophages, with CD163 associated with the protumoral phenotype and CD169 with activation of tumor immunity. This review comprehensively explores the dualistic roles of these markers in cancer progression and immune suppression, and discusses the mechanisms through which these markers influence macrophage behavior, the impact of their expression on cancer progression, and the therapeutic potential of targeting these pathways to reprogram the TME toward enhancing antitumor immunity. This review aims to underscore the therapeutic potential of macrophage activation markers as targets for cancer treatment, highlighting emerging strategies and future directions in cancer immunotherapy.
- 12 November 2025
- Published by Wiley in Pathology International
- Vol. 75 (11) , 551-561
Therapeutic Strategies Targeting CD163 and CD169 in Macrophages for Cancer
Macrophage activation markers, specifically CD163 and CD169, play pivotal roles in the modulation of immune responses within the tumor microenvironment (TME), influencing the outcome of various cancers. These markers delineate the activation states of macrophages, with CD163 associated with the protumoral phenotype and CD169 with activation of tumor immunity. This review comprehensively explores the dualistic roles of these markers in cancer progression and immune suppression, and discusses the mechanisms through which these markers influence macrophage behavior, the impact of their expression on cancer progression, and the therapeutic potential of targeting these pathways to reprogram the TME toward enhancing antitumor immunity. This review aims to underscore the therapeutic potential of macrophage activation markers as targets for cancer treatment, highlighting emerging strategies and future directions in cancer immunotherapy.
- 16 August 2025
- Published by Wiley in Hepatology Research
- Vol. 55 (11) , 1541-1550
SOX9 Is a Key Factor for the Postnatal Maturation of the Intrahepatic Bile Duct Network
Aim: The sex‐determining region Y‐box 9 (SOX9) plays a critical role in the development of intrahepatic bile ducts (IHBDs) during the embryonic stage. However, its role in postnatal IHBD maturation remains unclear. This study aimed to investigate the function of SOX9 in the postnatal development of the bile duct network, with particular emphasis on its role in structural organization. Methods: Three‐dimensional imaging analysis was conducted using a mouse model in which SOX9 deficiency is predominant after birth to assess the structural organization of IHBDs. Additionally, transcriptional profiling was performed in Sox9 conditional knockout (cKO) mice to elucidate mechanisms underlying abnormal IHBD morphogenesis. Results: In Sox9 cKO mice, bile ductules were significantly reduced in the middle region at 1, 5, and 10 weeks, whereas a ductular reaction was observed in the peripheral region at 5 and 10 weeks, likely in response to cholestatic liver injury, compared to control mice. SOX9 was essential for IHBD maturation and structural organization, in particular, in establishing connections between bile ductules and also between bile ductules and bile canaliculi. Furthermore, transcriptome analysis of Sox9 cKO mice revealed activation of compensatory pathways involved in bile acid transport and metabolism, whereas intercellular adhesion pathways were downregulated. Conclusions: These findings underscore the pivotal role of SOX9 in postnatal bile duct network development, demonstrating its critical involvement in maintaining structural organization. The results suggest that SOX9 plays a more substantial role in bile duct maturation than previously recognized, providing new insights into its regulatory mechanisms in liver development.
- 16 August 2025
- Published by Wiley in Hepatology Research
- Vol. 55 (11) , 1541-1550
SOX9 Is a Key Factor for the Postnatal Maturation of the Intrahepatic Bile Duct Network
Aim: The sex‐determining region Y‐box 9 (SOX9) plays a critical role in the development of intrahepatic bile ducts (IHBDs) during the embryonic stage. However, its role in postnatal IHBD maturation remains unclear. This study aimed to investigate the function of SOX9 in the postnatal development of the bile duct network, with particular emphasis on its role in structural organization. Methods: Three‐dimensional imaging analysis was conducted using a mouse model in which SOX9 deficiency is predominant after birth to assess the structural organization of IHBDs. Additionally, transcriptional profiling was performed in Sox9 conditional knockout (cKO) mice to elucidate mechanisms underlying abnormal IHBD morphogenesis. Results: In Sox9 cKO mice, bile ductules were significantly reduced in the middle region at 1, 5, and 10 weeks, whereas a ductular reaction was observed in the peripheral region at 5 and 10 weeks, likely in response to cholestatic liver injury, compared to control mice. SOX9 was essential for IHBD maturation and structural organization, in particular, in establishing connections between bile ductules and also between bile ductules and bile canaliculi. Furthermore, transcriptome analysis of Sox9 cKO mice revealed activation of compensatory pathways involved in bile acid transport and metabolism, whereas intercellular adhesion pathways were downregulated. Conclusions: These findings underscore the pivotal role of SOX9 in postnatal bile duct network development, demonstrating its critical involvement in maintaining structural organization. The results suggest that SOX9 plays a more substantial role in bile duct maturation than previously recognized, providing new insights into its regulatory mechanisms in liver development.